Acute Myeloid Leukemia With KMT2A Amplification: A TP53-Alteration-Enriched Subgroup Associated With Chromoanagenesis and Poor Prognosis

Modern Pathology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles